🔴 Voyager Therapeutics is trading 5.36% down in pre-market

Voyager Therapeutics is trading 5.36% down at $3.00, versus its August 10 closing price of $3.17; no clear overnight catalyst was identified.

• No new August 10–11 company announcement was identified in the press-release archive; the latest listed release was July 13.
• The August 6 quarterly report was mixed, showing a $24.47 million loss and a $0.40 loss per share, but no clear overnight catalyst directly explains the pre-market decline.